Table 3.

Effects of IFN- γ , AA, BPB, Pertussis Toxin, and Herbimycin A on Sphingomyelin and Ceramide Levels in HL-60 Cells

TreatmentSphingomyelin (% control)Ceramide (pmol/mg of protein)
ControlIFN-γAAControlIFN-γAA
None 100 ± 3.7 74.2 ± 5.33-150 73.8 ± 5.13-150 18.3 ± 1.9 41.5 ± 3.93-150 44.2 ± 4.33-150 
BPB 102.1 ± 5.3 97.6 ± 4.2 74.1 ± 4.23-150 17.9 ± 1.6 18.1 ± 1.7 43.7 ± 3.63-150 
Pertussis toxin 103.2 ± 4.3 102.1 ± 3.7 73.7 ± 3.63-150 17.5 ± 2.2 19.1 ± 2.1 42.8 ± 5.13-150 
Herbimycin A 101.5 ± 3.7 75.6 ± 4.23-150 ND 18.5 ± 2.1 42.1 ± 4.33-150 ND 
TreatmentSphingomyelin (% control)Ceramide (pmol/mg of protein)
ControlIFN-γAAControlIFN-γAA
None 100 ± 3.7 74.2 ± 5.33-150 73.8 ± 5.13-150 18.3 ± 1.9 41.5 ± 3.93-150 44.2 ± 4.33-150 
BPB 102.1 ± 5.3 97.6 ± 4.2 74.1 ± 4.23-150 17.9 ± 1.6 18.1 ± 1.7 43.7 ± 3.63-150 
Pertussis toxin 103.2 ± 4.3 102.1 ± 3.7 73.7 ± 3.63-150 17.5 ± 2.2 19.1 ± 2.1 42.8 ± 5.13-150 
Herbimycin A 101.5 ± 3.7 75.6 ± 4.23-150 ND 18.5 ± 2.1 42.1 ± 4.33-150 ND 

[3H]Choline-labeled or unlabeled HL-60 cells were preincubated with BPB (10 μmol/L) for 10 minutes, pertussis toxin (20 ng/mL) for 18 hours or herbimycin A (1 μg/mL) for 14 hours and then treated or not with either IFN-γ (2,000 U/mL) or AA (10 μmol/L) for 2 hours. After incubation, cells were harvested, lipids were extracted, and SM levels were determined by TLC, while ceramide levels were determined using DAG kinase assay. The data (means ± SD) are from three independent experiments assayed in duplicate.

Abbreviation: ND, not determined.

F3-150

Significantly different (P < .05, Student's t-test) from controls.

or Create an Account

Close Modal
Close Modal